Trial of Ipilimumab After Isolated Limb Perfusion, in Patients With Metastases Melanoma
Clinical trial NCT02094391 · COMPLETED
Trial details
- NCT number
- NCT02094391
- Sponsor
- Gustave Roussy, Cancer Campus, Grand Paris
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-03-01
- Primary completion
- 2016-02-01
- Enrollment
- 4
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.